Cardinal Health Pays Nearly $9M To Resolve FCPA Claims
The U.S. Securities and Exchange Commission announced Friday that pharmaceutical company Cardinal Health Inc. has agreed to pay almost $9 million to resolve allegations that its Chinese subsidiary violated the Foreign...To view the full article, register now.
Already a subscriber? Click here to view full article